Is Vascepa Available for International Purchase?
Vascepa (icosapent ethyl) is approved and marketed primarily in the United States by Amarin Pharma for reducing cardiovascular risk in specific patients. It is not broadly available for direct international purchase outside the US due to varying regulatory approvals and distribution restrictions.[1]
Which Countries Approve Vascepa?
The European Medicines Agency (EMA) approved Vascepa in 2021 under the brand name Vazkepa for EU member states, Iceland, Norway, and Liechtenstein. It is available by prescription in these regions through local pharmacies.[2] Japan approved it in 2022 as Epadel ACE, but this is a different formulation and brand from Amarin's product.[3] It lacks approval in Canada, Australia, the UK (post-Brexit), or most other countries, limiting legal access.[1][2]
How to Get Vascepa Outside the US and Approved Regions?
Patients in unapproved countries cannot legally purchase Vascepa directly from manufacturers or standard pharmacies. Options include:
- Importing via special regulatory waivers (e.g., named-patient programs in the EU or India), though this requires a doctor's prescription and incurs high costs plus customs risks.
- Clinical trials or expanded access programs, which are rare and location-specific.
Online gray-market sellers exist but violate patent and import laws, risking counterfeit drugs or seizures.[4]
What Are the Barriers to Global Availability?
Patent protections and pricing strategies restrict exports. Amarin holds US exclusivity until around 2030 (with pediatric extensions possible), and similar patents apply in Europe.[5] High list prices ($300+ monthly in the US) deter international expansion without local partnerships. Supply chain limits focus on approved markets to avoid shortages.[1][5]
Alternatives Available Internationally
Pure EPA omega-3 products like Lovaza (prescription) or generic icosapent ethyl equivalents are available in some countries (e.g., Canada, India). Over-the-counter fish oil supplements are widely sold globally but lack Vascepa's purity and proven CV benefits.[6]
[1]: FDA Label for Vascepa
[2]: EMA Approval for Vazkepa
[3]: PMDA Japan Approval
[4]: WHO on Drug Import Regulations
[5]: DrugPatentWatch.com - Vascepa Patents
[6]: REDUCE-IT Trial Summary